Oxalic Acid

Oxalic Acid

SCHEMBL6773000

CC1(C)Cc2cccc(C3CCN(CCc4c[nH]c5cc(Cl)ccc45)CC3)c2O1.O=C(O)C(=O)O

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 known ✓ P35372 1/20 0.39
SLC6A4 known ✓ P31645 2/20 0.38
KCNH2 Q12809 6/20 0.48
HTR6 P50406 5/20 0.48
DRD2 P14416 2/20 0.41
ADRA2A P08913 1/20 0.40
ADRA2B P18089 1/20 0.40
ADRA2C P18825 1/20 0.40
ADRA1D P25100 1/20 0.40
ADRA1A P35348 1/20 0.40
ADRA1B P35368 1/20 0.40
AVPR1A P37288 1/20 0.39
OPRK1 P41145 1/20 0.39
OPRL1 P41146 1/20 0.39
HTR7 P34969 3/20 0.38
DRD4 P21917 2/20 0.38
SOS1 Q07889 1/20 0.38
HRH1 P35367 1/20 0.38
DRD3 P35462 1/20 0.38
HTR2B P41595 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6592028 0.95 KCNH2 (0.47) KCNH2HTR6DRD2ADRA1DADRA1B
Fumaric Acid SCHEMBL6783145 0.85 HTR6 (0.41) KCNH2HTR6DRD2ADRA2AADRA2B
Fumaric Acid SCHEMBL6783149 0.85 HTR6 (0.41) KCNH2HTR6DRD2ADRA2AADRA2B
SCHEMBL6588465 0.84 HTR6 (0.42) KCNH2HTR6DRD2OPRM1OPRK1
Fumaric Acid SCHEMBL6593123 0.80 DRD2 (0.53) KCNH2HTR6DRD2AVPR1AHTR7
Fumaric Acid SCHEMBL6772508 0.80 DRD2 (0.53) KCNH2HTR6DRD2AVPR1AHTR7
SCHEMBL6590553 0.80 DRD2 (0.60) KCNH2HTR6DRD2HTR7SLC6A4
SCHEMBL6588606 0.77 DRD2 (0.64) KCNH2HTR6DRD2SLC6A4DRD3
SCHEMBL6589659 0.76 HTR1D (0.45) HTR6DRD2HTR7SLC6A4HTR1A
SCHEMBL6588411 0.74 KCNH2 (0.49) KCNH2HTR6DRD2OPRM1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6727263-B2 SEROTONINE REUPTAKE INHIBITOR; ANTIDEPRESSANTS; SIDE EFFECT REDUCTION H. LUNDBECK A/S (DK) 2004-04-27 US disclosed
US-20030018050-A1 Indole and 2,3-dihydroindole derivatives, their preparation and use H. LUNDBECK A/S (DK) 2003-01-23 US disclosed
US-6476035-B1 Indole and 2,3-dihydroindole derivatives, their preparation and use H. LUNDBECK A/S (DK) 2002-11-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030018050-A1 Indole and 2,3-dihydroindole derivatives, their preparation and use TPH1, HTR1A, HTR3A OPRM1 41/4885SLC6A4 25/4885KCNH2 1191/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.